These are exciting times for cancer research. The rapid evolution and decreasing cost of omics technologies provide unprecedented opportunities to improve individual patient diagnosis, prognosis, and treatment. To fully realize this goal, however, requires integrating and analyzing data from the laboratory and the clinic in a way that is meaningful and useful to health-care providers. …
